Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Advanced or Inoperable Gastric Cancer
In brief
This study enrolled participants with previously-treated advanced or inoperable gastric cancer who have responded to first line platinum therapy into two treatment arms. In Arm A participants received BGB-290; in Arm B participants received placebo. The purpose of this study is to show that BGB-290 (pamiparib) (versus placebo) will improve progression-free survival (PFS) in participants with advanced or inoperable gastric cancer.
Key facts
- Study ID
- NCT03427814
- Run by
- BeiGene
- People needed
- 136
- Starts
- 2018-07-03
- Expected to finish
- 2023-01-03
- Last updated by the study team
- 2024-10-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Scri Florida Cancer Specialist East — West Palm Beach, Florida, United States
- Goshen Center For Cancer Care — Goshen, Indiana, United States
- Cancer Center of Kansas — Wichita, Kansas, United States
- Norton Cancer Institute — Louisville, Kentucky, United States
- Novant Health Hematology Charlotte — Charlotte, North Carolina, United States
- Oregon Health and Science University — Portland, Oregon, United States
- Gosford Hospital — Gosford, New South Wales, Australia
- Monash Health — Clayton, Victoria, Australia
- Ballarat Oncology and Haematology Services — Wendouree, Victoria, Australia
- St John of God Health Care — Subiaco, Western Australia, Australia
- Az Sint Jan Brugge — Bruges, Belgium
- University Hospitals Leuven — Leuven, Belgium
- Anhui Provincial Hospital — Hefei, Anhui, China
- Beijing Cancer Hospital — Beijing, Beijing Municipality, China
- Sun Yat Sen University Cancer Center — Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University — Guangzhou, Guangdong, China
- Cancer Hospital of Shantou University Medical College — Shantou, Guangdong, China
- Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School — Nanjing, Jiangsu, China
- Liaoning Cancer Hospital and Institute — Shenyang, Liaoning, China
- Shandong Cancer Hospital — Jinan, Shandong, China
- The Affiliated Hospital of Qingdao University Branch South — Qingdao, Shandong, China
- Affiliated Zhongshan Hospital of Fudan University — Shanghai, Shanghai Municipality, China
- Fakultni Nemocnice Bulovka — Prague, Czechia
- Chru de Brest Hospital Morvan — Brest, France
- Miami Cancer Institute — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.